US Stock MarketDetailed Quotes

GRTX Galera Therapeutics

Watchlist
  • 0.190
  • +0.004+2.10%
Trading Apr 29 11:50 ET
10.33MMarket Cap-142P/E (TTM)

About Galera Therapeutics Company

Galera Therapeutics, Inc. is a clinical stage biotechnology company, which engages in developing and commercializing a pipeline of novel, proprietary therapeutics for cancer. It is also involved in the prevention of radiation-induced toxicity, including mucositis and the treatment of fibrosis, and cancer. The company was founded by Robert A. Beardsley, Randy W. Weiss, and Dennis P. Riley in 2009 and is headquartered in Malvern, PA.

Company Profile

SymbolGRTX
Company NameGalera Therapeutics
Listing DateNov 7, 2019
Issue Price12.00
Founded2009
CEODr. J. Mel Sorensen, M.D.
MarketNASDAQ
Employees7
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
AddressP. O. Box 134
CityMalvern
ProvincePennsylvania
CountryUnited States of America
Zip Code19355
Phone1-610-725-1500
Websitehttp://www.galeratx.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. J. Mel Sorensen, M.D.
  • Director, President and Chief Executive Officer
  • 1.36M
  • Eugene P. Kennedy, M.D.
  • Chief Medical Officer
  • --
  • Robert A. Beardsley, PhD
  • Chief Operating Officer
  • 423.41K
  • Christopher Degnan
  • Chief Financial Officer and Principal Accounting Officer
  • 834.87K
  • Jennifer Evans Stacey, Esq.
  • Chief Legal and Compliance Officer and Secretary
  • --
  • Dr. Michael F. Powell, PhD
  • Chairman of the Board
  • 90.26K
  • Dr. Emmett Cunningham, M.D.,M.P.H.,PhD
  • Director
  • 51.69K
  • Kevin G. Lokay
  • Independent Director
  • 68.19K
  • Linda West
  • Independent Director
  • 101.45K
  • Lawrence M. Alleva
  • Independent Director
  • 71.69K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg